Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Inhibition of epileptiform activity by neuropeptide Y in brain tissue from drug-resistant temporal lobe epilepsy patients

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A prospective three-year follow-up study on the clinical significance of anti-neuronal antibodies in acute psychiatric disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A Weighted Genetic Risk Score of Adult Glioma Susceptibility Loci Associated with Pediatric Brain Tumor Risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Leukocyte telomere length is associated with elevated plasma glucose and HbA1c in young healthy men independent of birth weight

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Collagen turnover profiles in chronic kidney disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Diagnostic added value of electrical source imaging in presurgical evaluation of patients with epilepsy: A prospective study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Why are antiepileptic drugs continued after successful epilepsy surgery in adults?

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Diagnostic yield of high-density versus low-density EEG: The effect of spatial sampling, timing and duration of recording

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Transcriptome analysis in patients with temporal lobe epilepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

In epilepsy patients, drug-resistant seizures often originate in one of the temporal lobes. In selected cases, when certain requirements are met, this area is surgically resected for therapeutic reasons. We kept the resected tissue slices alive in vitro for 48 h to create a platform for testing a novel treatment strategy based on neuropeptide Y (NPY) against drug-resistant epilepsy. We demonstrate that NPY exerts a significant inhibitory effect on epileptiform activity, recorded with whole-cell patch-clamp, in human hippocampal dentate gyrus. Application of NPY reduced overall number of paroxysmal depolarising shifts and action potentials. This effect was mediated by Y2 receptors, since application of selective Y2-receptor antagonist blocked the effect of NPY. This proof-of-concept finding is an important translational milestone for validating NPY-based gene therapy for targeting focal drug-resistant epilepsies, and increasing the prospects for positive outcome in potential clinical trials.

Original languageEnglish
JournalScientific Reports
Volume9
Issue number1
Pages (from-to)19393
ISSN2045-2322
DOIs
Publication statusPublished - 18 Dec 2019

ID: 58940603